Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) were up 1.6% on Wednesday . The stock traded as high as C$0.33 and last traded at C$0.33. Approximately 53,600 shares traded hands during trading, an increase of 19% from the average daily volume of 45,129 shares. The stock had previously closed at C$0.32.
Nanalysis Scientific Stock Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The stock has a 50-day moving average of C$0.33 and a 200-day moving average of C$0.37. The firm has a market cap of C$36.74 million, a price-to-earnings ratio of -2.71 and a beta of 0.72.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Further Reading
- Five stocks we like better than Nanalysis Scientific
- What Is WallStreetBets and What Stocks Are They Targeting?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is Forex and How Does it Work?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Are Some of the Best Large-Cap Stocks to Buy?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
